Physician

Paul Jensen, M.D.

According to 2025 Medicare claims, Paul Jensen, M.D. (NPI: 1851617898) practices internal medicine in the St. George, UT market, with the plurality of this provider's patient population coming from Washington, UT. This provider's primary affiliated billing organization is IHC HEALTH SERVICES, INC. (NPI: 1093246720; TIN: 942854057) and primary practice location at 84790-2097. Jensen is affiliated with the Castell Accountable Care, LLC (ACO ID: D0136), participating under the REACH model.

Jensen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 257 traditional Medicare patients, billed 66,818 HCPCS/CPT codes, and received $810,134 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,544 prescription claims across 320 beneficiaries totaling $1,449,811 in drug costs, led by Enbrel Sureclick (Etanercept). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $137,527 to $810,134. Similarly, Part D prescription costs have risen steadily, from $65,948 to $1,449,811. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$405K$810K2019 Medicare payment: $137,527 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $149,341 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $149,520 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $116,918 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $96,275 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $810,134 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20193528,903$137,527
202035214,066$149,341
202134212,917$149,520
20223027,434$116,918
20232722,781$96,275
202425766,818$810,134

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$803K$1.6M2015 Drug cost: $65,948 (USD; Tot_Drug_Cst)2016 Drug cost: $196,241 (USD; Tot_Drug_Cst)2017 Drug cost: $78,340 (USD; Tot_Drug_Cst)2018 Drug cost: $264,855 (USD; Tot_Drug_Cst)2019 Drug cost: $1,046,612 (USD; Tot_Drug_Cst)2020 Drug cost: $1,606,333 (USD; Tot_Drug_Cst)2021 Drug cost: $1,053,040 (USD; Tot_Drug_Cst)2022 Drug cost: $1,396,515 (USD; Tot_Drug_Cst)2023 Drug cost: $1,132,219 (USD; Tot_Drug_Cst)2024 Drug cost: $1,449,811 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201542189$65,948
201652254$196,241
201721152$78,340
2018133529$264,855
20193051,928$1,046,612
20203452,515$1,606,333
20213822,259$1,053,040
20223542,427$1,396,515
20233432,424$1,132,219
20243202,544$1,449,811

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more5159$119
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more214452$86
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less42230$46
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's160272$12
96372Injection of drug or substance under skin or into muscle3065$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept361,008$264,744
BenlystaBelimumab391,092$194,045
Humira(Cf) PenAdalimumab25700$156,325
EnbrelEtanercept19532$135,625
Cimzia (2 Pack)Certolizumab Pegol13588$128,888

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Paul Jensen, M.D.?

Tedicare shows public-source Medicare data for Paul Jensen, M.D. (NPI 1851617898), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul Jensen, M.D. have ACO affiliation data?

Paul Jensen, M.D. is shown with ACO affiliation data for Castell Accountable Care, LLC (REACH, ACO ID D0136).

What billing organization is linked to Paul Jensen, M.D.?

Paul Jensen, M.D. is linked to IHC HEALTH SERVICES, INC. (billing NPI 1093246720) in the available physician profile data.

Does Paul Jensen, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.